The 20 Best Chordoma Doctors in Maryland, US

Dr. Gary Gallia's specialty is endoscopic endonasal surgical approaches to skull base pathologies with a focus on neurosurgical oncology. He utilizes the latest techniques in preoperative imaging, computer-guided surgical navigation, intraoperative monitoring, and minimally invasive and Neuroendoscopy approaches in the management of patients with benign and malignant brain tumors, metastatic tumors to the brain, skull base neoplasms, and pituitary tumors. He is the director of the Neurosurgery Skull Base Center and surgical director of the Johns Hopkins Pituitary Center. Dr. Gary Gallia graduated summa cum laude from the Gibbons Scholar MD/PhD program at Jefferson Medical College and Thomas Jefferson University. He completed his general surgery internship at The Johns Hopkins Hospital where he was awarded surgical intern of the year. He then completed his neurological surgery residency and a postdoctoral fellowship in neuro-oncology at The Johns Hopkins Hospital. Following residency, he completed a minimally invasive and endoscopic neurosurgery fellowship with Dr. Charles Teo at the Prince of Wales Private Hospital and Sydney Children's Hospital in Sydney, Australia. Dr. Gallia is rated as an Elite provider by MediFind in the treatment of Chordoma. His top areas of expertise are Olfactory Neuroblastoma, Chordoma, Pituitary Tumor, Awake Craniotomy, and Craniectomy.

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is rated as a Distinguished provider by MediFind in the treatment of Chordoma. Her top areas of expertise are Brain Tumor, Chordoma, Astrocytoma, and Metastatic Brain Tumor.

Chetan Bettegowda is the director of the Johns Hopkins Department of Neurosurgery. He offers comprehensive treatments for adult patients with benign and malignant brain tumors, specializing in the treatment of patients with primary brain tumors such as gliomas, meningiomas and pituitary tumors. He performs both open surgery and stereotactic radiosurgery for patients with metastatic tumors to the brain, and also provides stereotactic radiosurgery for other neurological disorders, including spinal tumors, trigeminal neuralgia and skull-base tumors. Dr. Bettegowda is rated as a Distinguished provider by MediFind in the treatment of Chordoma. His top areas of expertise are Trigeminal Neuralgia, Astrocytoma, Glioblastoma, Rhizotomy, and Microvascular Decompression.

Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Chordoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, Fibrosarcoma, Osteosarcoma, and Salpingo-Oophorectomy.

Daniel Lubelski is a fellowship-trained neurosurgeon with expertise in complex spine surgery and peripheral nerve surgery. He treats patients with spinal diseases and deformities, spine and nerve tumors, and brachial plexus injuries and other peripheral nerve injuries. Dr. Lubelski’s training in complex and robotic spine surgery, spinal oncology and peripheral nerve injuries allows him to comprehensively evaluate patients and develop custom treatment plans to address symptoms and improve patients’ quality of life. He prioritizes patient-centered care, effective communication and working in multidisciplinary collaboration to identify the best treatment. After obtaining his undergraduate degree at the City University of New York, Dr. Lubelski spent a year doing predoctoral research at the National Institutes of Health. He then obtained his medical degree from the Cleveland Clinic Lerner College of Medicine, and he performed stem cell tumor research as a Howard Hughes Medical Institute fellow. Dr. Lubelski went on to the Johns Hopkins University School of Medicine for a neurosurgery residency and an enfolded fellowship in peripheral nerve surgery. His postdoctoral training also included a fellowship in complex spine surgery and spinal oncology at Johns Hopkins, as well as a traveling fellowship with advanced training at the Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. Dr. Lubelski is a prolific researcher who focuses on patient quality of life and on using big data to develop individualized prediction models to determine optimal treatments tailored to each person. He has authored more than 200 peer-reviewed papers and numerous textbook chapters, has lectured nationally and internationally, and serves as a reviewer for the top neurosurgical journals. Dr. Lubelski is rated as a Distinguished provider by MediFind in the treatment of Chordoma. His top areas of expertise are Spinal Tumor, Chordoma, Spinal Stenosis, Spinal Fusion, and Laminectomy.

Dr. Debraj “Raj” Mukherjee’s clinical focus is the treatment of patients with primary and metastatic brain lesions. His clinical work and research emphasize the development of individual treatment plans that optimize survival and quality of life in all patients. After receiving his medical degree from Dartmouth Medical School, Dr. Mukherjee was recruited to Johns Hopkins, where he studied epidemiology, biostatistics and clinical design at the Johns Hopkins Bloomberg School of Public Health and served as Director of the Neuro-Oncology Surgical Outcomes Laboratory in the Department of Neurosurgery. Dr. Mukherjee completed neurosurgery residency at Cedars-Sinai Medical Center, where he was named a Robert Wood Johnson Foundation Health & Society Scholar. He completed an open and endoscopic skull base fellowship with the Center for Skull Base Surgery at University of Pittsburgh Medical Center, where he was a Copeland Scholar. Throughout his career, Dr. Mukherjee has led patient-centered research pursuits in neuro-oncology including development of a national registry for patients with brain tumors, creation of disease-specific quality of life instruments for patients with skull base tumors, and development of innovative clinical trials in neuro-oncology. He leads the Meningioma, Brain Metastasis, and Neurosurgical Oncology centers at Johns Hopkins Medicine, and he serves as Assistant Residency Program Director for one of the largest neurosurgical training programs in the country. His work has been supported by the American Medical Association, Glioblastoma Foundation, National Institute on Aging, and National Cancer Institute. Dr. Mukherjee can be contacted at drraj@jhmi.edu. Dr. Mukherjee is rated as a Distinguished provider by MediFind in the treatment of Chordoma. His top areas of expertise are Meningioma, Pituitary Tumor, Brain Tumor, Awake Craniotomy, and Craniectomy.

Dr. Timothy Witham is a professor of neurological surgery and orthopaedic surgery at the Johns Hopkins University School of Medicine. His interests include the surgical treatment of degenerative conditions of the cervical and lumbar spine, including instrumented fusion procedures. He also has an expertise in the treatment of spinal tumors, spinal trauma and spinal deformity. Dr. Witham serves as director of the Johns Hopkins Neurosurgery Spinal Fusion Laboratory, director of Johns Hopkins Bayview Medical Center's Spine Program and co-program director of the Johns Hopkins Neurosurgery Residency Program. Dr. Witham received his B.S. in biochemistry from the Pennsylvania State University. He earned his M.D. from the Johns Hopkins University School of Medicine. He completed his residency at the University of Pittsburgh Medical Center. He performed a fellowship in spinal neurosurgery at Johns Hopkins. Dr. Witham joined the Johns Hopkins faculty in 2005. Prior to joining Johns Hopkins, Dr. Witham was chief neurosurgeon at Keesler Medical Center at Keesler Air Force Base in Biloxi, Mississippi. Dr. Witham's research interests include finding novel ways to achieve spinal fusion and improving surgical techniques in the aging spine. A co-author of more than 170 peer-reviewed articles and abstracts, Dr. Witham has been featured as a “Top Doctor” in Baltimore magazine and was a recipient of a United States Air Force meritorious service medal in 2005. He is a member of various professional organizations, including the American College of Surgeons and American Association of Neurological Surgeons. Dr. Witham is rated as an Advanced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Spinal Stenosis, Cervical Spondylosis, Bone Tumor, Spinal Fusion, and Laminectomy.

Dr. Ali Bydon is a renowned neurosurgeon and director of the Division of Spine Surgery and the Neurosurgical Spine Center at the Johns Hopkins University School of Medicine. As the endowed Ziya Gokaslan Professor of Neurosurgery, he is dedicated to advancing the field through innovative clinical practices and extensive research. Additionally, Dr. Bydon serves as the vice chair for strategic planning within the Department of Neurosurgery. Dr. Bydon’s clinical practice is centered on degenerative disorders of the spine, spinal tumors, spinal trauma and complex spinal reconstruction. He is an esteemed member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. Dr. Bydon earned his medical degree from the University of Michigan School of Medicine in 1999 and completed his residency in neurological surgery at Henry Ford Hospital in Detroit, where he graduated with distinction in 2006. He further honed his skillset by completing fellowships in minimally invasive spine surgery and the surgical treatment of peripheral nerves, followed by a one-year instructorship in spinal oncology and complex reconstructive spinal surgery at Johns Hopkins in 2007. His research focuses on spinal biomechanics and surgical outcomes. He has co-authored over 265 peer-reviewed manuscripts and numerous book chapters. Dr. Bydon has made significant contributions to the understanding of optimal surgical management for conditions such as spinal synovial cysts, cervical myelopathy, lumbar spondylolisthesis, ossified posterior longitudinal ligament, cervical degenerative disorders, cervical myelopathy, thoracic myelopathy and metastatic diseases to the spine, among others. Dr. Bydon has presented at more than 200 national and international scientific meetings, underscoring his commitment to advancing knowledge in the field. An educator who has trained over 75 practicing neurosurgeons, Dr. Bydon has received prestigious accolades, including the Richard Otenasak Faculty Teaching Award and the Chairman’s Neurosurgical Teacher of the Year Award. His leadership roles have included serving on the residency review committee and the patient access committee at Johns Hopkins, as well as a yearlong term as the neurosurgical representative on the Johns Hopkins Faculty Senate. He has also served as a medical director with Johns Hopkins Medicine International, overseeing clinical and educational activities at renowned institutions in Lebanon and Brazil. Dr. Bydon has performed more than 5,000 surgeries. His commitment to excellence in patient care, education and research makes him a leading authority in spine surgery, dedicated to providing transformative care to patients seeking relief and recovery. Dr. Bydon is rated as an Advanced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Spinal Stenosis, Spondylolisthesis, Invertebral Disc Disease, Laminectomy, and Spinal Fusion.

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is rated as an Advanced provider by MediFind in the treatment of Chordoma. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Squamous Cell Lung Carcinoma, and Non-Small Cell Lung Cancer (NSCLC).

James Gulley is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Gulley is rated as a Distinguished provider by MediFind in the treatment of Chordoma. His top areas of expertise are Prostate Cancer, Olfactory Neuroblastoma, Chordoma, Urothelial Cancer, and Orchiectomy.

Ravi Madan is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Madan is rated as a Distinguished provider by MediFind in the treatment of Chordoma. His top areas of expertise are Prostate Cancer, Chordoma, Medullary Thyroid Carcinoma, Orchiectomy, and Prostatectomy.

Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is rated as an Experienced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Glioma, and Hepato-Pancreato-Biliary Surgery.

Jordina Rincon-Torroella is a fellowship-trained neurosurgeon specializing in the surgical treatment of benign and malignant tumors of the brain and skull base, such as meningiomas, gliomas, pituitary tumors and metastatic brain tumors, to name a few. Dr. Rincon-Torroella earned her medical degree from the University of Barcelona medical school. She completed a postdoctoral fellowship in neurosurgical oncology at Johns Hopkins University, where she remained for residency training in neurosurgery. She completed an additional postdoctoral fellowship in cancer research and drug development at Johns Hopkins in the Ludwig Center under the mentorship of neurosurgeon Chetan Bettegowda and molecular biologist and geneticist Bert Vogelstein. Active in clinical research since 2010, Dr. Rincon-Torroella has published numerous research papers. She is also a peer reviewer for several journals and has edited two books, most recently The Neurosurgical Consult Book. Dr. Rincon-Torroella is fluent in Catalan, English and Spanish. Dr. Torroella is rated as an Experienced provider by MediFind in the treatment of Chordoma. Her top areas of expertise are Subependymoma, Ependymoma, Brain Tumor, Laminectomy, and Craniectomy.

Christopher Jackson is a neurosurgeon who specializes in brain tumors and cerebrovascular disorders, including glioma, meningioma, acoustic neuroma, trigeminal neuralgia, brain metastasis, arteriovenous malformation, and aneurysms. He is the director of the Acoustic Neuroma Center. Dr. Jackson earned his medical degree from the Johns Hopkins University School of Medicine, where he also completed his neurosurgical residency. During his residency, Dr. Jackson was honored with multiple distinctions, including the Frank L. Coulson Jr. Award for Clinical Excellence, the Irving J. Sherman Award for Resident Achievement, the Harvey Cushing Hunterian Research Award, and was elected to Alpha Omega Alpha. Dr. Jackson is an active researcher who has published over 35 peer-reviewed articles on brain tumor and cerebrovascular immunology. His laboratory focuses on how brain tumors evade the immune system and become resistant to immunotherapy. Additionally, Dr. Jackson’s laboratory explores the formation of cerebral aneurysms and inflammatory complications of cerebral aneurysm rupture. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Trigeminal Neuralgia, Meningioma, Glioblastoma, Rhizotomy, and Microvascular Decompression.

Henry Brem is a Neurosurgery provider in Baltimore, Maryland. Dr. Brem is rated as an Experienced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Gliosarcoma, Glioma, Gliomatosis Cerebri, Osteotomy, and Posterior Fossa Decompression.

Sang Hun Lee, M.D., Ph.D, is a fellowship-trained spine surgeon with expertise in complex cervical spine (neck) and spine tumor surgery. Dr. Lee specializes in the latest orthopaedic and neurosurgical techniques in cervical spine degenerative disc disease, cervical spine minimally invasive procedures, cervical spine deformities, cervical spinal reconstruction, and management of spinal tumors (primary and metastatic spine tumors). Dr. Lee is also performing endoscopic spine surgeries, which is the most technically advanced minimally invasive spine surgery for cervical and lumbar disc herniation or spinal stenosis using uniportal or biportal endoscopic procedures. Dr. Lee was a Full Professor and taught numerous residents and fellows in South Korea from 1999 to 2015, and he became a renowned cervical spine expert in the Asia-Pacific region. As a founding member of Korean and Asian Pacific Cervical Spine, Minimally Invasive Spine Surgery and Spinal Tumor Research Societies, Dr. Lee has been a key speaker and thought leader at numerous international spine meetings. He has also been invited to visit and operate with leading spine surgeons in the U.S., Japan and around the world. Dr. Lee regularly teaches other surgeons at national and international meetings on safety and efficiency when performing cervical spine surgery, the latest techniques in the field and strategies for complication avoidance. He has been on the faculty at the Cervical Spine Research Society meetings and the instructional courses. Dr. Lee is an international expert on diagnosis, nonsurgical and surgical treatment of cervical spine conditions and spine tumors. He has authored or co-authored more than 100 peer-reviewed publications, book chapters and articles on diagnosis and treatment of spinal conditions. His work has resulted in numerous research awards and podium presentations. Dr. Lee completed his M.D. and Ph.D. degrees at the prestigious Kyung Hee University, School of Medicine in Seoul, South Korea. He completed his orthopaedic surgery residency and spine fellowship at Kyung Hee University hospital in Seoul, one of the most prestigious programs in Asia. Dr. Lee also pursued advanced spinal tumor and neurosurgical oncology training at the prestigious MD Anderson Cancer Center in Houston, Texas, where he worked with world-experts on complex spinal tumor reconstructive surgery. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Kyphosis, Spinal Stenosis, Scoliosis, Laminectomy, and Bone Graft.

Tejan Diwanji is a Radiologist and a Radiation Oncologist in Halethorpe, Maryland. Dr. Diwanji is rated as an Experienced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, and Brain Tumor. Dr. Diwanji is currently accepting new patients.

Amin Amini is a Neurosurgery provider in Silver Spring, Maryland. Dr. Amini is rated as an Advanced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Subdural Hematoma, Cervical Myelopathy, Normal Pressure Hydrocephalus, Vertebroplasty, and Bone Graft.

Katherine Thornton is an Oncologist in Baltimore, Maryland. Dr. Thornton is rated as an Advanced provider by MediFind in the treatment of Chordoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Angiosarcoma, Synovial Sarcoma, and Bone Tumor.

Alessandro Olivi is a Neurosurgery provider in Baltimore, Maryland. Dr. Olivi is rated as an Advanced provider by MediFind in the treatment of Chordoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Microvascular Decompression, and Craniectomy.